Common Contracts

COLLABORATION AND LICENSE AGREEMENT

Collaboration and License Agreement • April 16th, 2020 • England and Wales

• Contract Type
  Collaboration and License Agreement
• Filed
  April 16th, 2020
• Jurisdiction
  England and Wales

made and entered into this August 14, 2012 (the “Effective Date”), by and between AstraZeneca AB, a company organized under the laws of Sweden (“AstraZeneca”) having a place of business at SE-431 83 Mölndal, Sweden, and Regulus Therapeutics Inc., a Delaware Corporation (“Regulus”) having a place of business at 3545 John Hopkins Court, San Diego, California 92121-1121, U.S.A. AstraZeneca and Regulus each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

COLLABORATION AND LICENSE AGREEMENT between REGULUS THERAPEUTICS INC. And ASTRAZENECA AB

Collaboration and License Agreement • August 17th, 2012 • Regulus Therapeutics Inc. • Pharmaceutical preparations • England and Wales

• Contract Type
  Collaboration and License Agreement
• Filed
  August 17th, 2012
• Company
  Regulus Therapeutics Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  England and Wales

THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is made and entered into this August 14, 2012 (the “Effective Date”), by and between ASTRAZENECA AB, a company organized under the laws of Sweden (“AstraZeneca”) having a place of business at SE-431 83 Mölndal, Sweden, and REGULUS THERAPEUTICS INC., a Delaware Corporation (“Regulus”) having a place of business at 3545 John Hopkins Court, San Diego, California 92121-1121, U.S.A. AstraZeneca and Regulus each may be referred to herein individually as a “Party,” or collectively as the “Parties.”